Search results
Study demonstrates how AI can develop more personalized cancer treatment strategies
Medical Xpress· 6 days agoAdaptive therapy strategies, which dynamically adjust treatment...Learning Enables Personalized Adaptive Therapy" published in Cancer Research, researchers from the University ...
Medicare must fund blood-based cancer screenings. NY's delegatin must act
Lohud | The Journal News via Yahoo News· 5 days agoAs this new innovation is awaiting approval by the Food and Drug Administration, or FDA, it is...
15 Life-Altering Moments In The Lives Of Cancer Survivors That Will Give You A New Perspective On...
BuzzFeed via Yahoo News· 4 days agoAnton Dobrea / Getty Images 9."I am 78 years old and at the age of 70, I was diagnosed with prostate...
America first declared war on cancer half a century ago. Today’s regulatory hurdles won’t help us...
Fortune via AOL· 5 days agoExciting new technologies can help the U.S. government win the war that it declared 50 years ago—but...
Medicare must fund blood-based cancer screenings. NY's delegatin must act
The Journal News· 5 days agoFinding out you or a loved one has cancer can be one of the more jarring experiences in our lives....
Huge boost as HPV jab found to slash rates of another major cancer in men
Daily Express· 7 days agoThousands of cases of head and neck cancer are set to be prevented thanks to the success of the HPV...
FDA Expands Orphan Drug Designation for SurVaxM, I | Newswise
Newswise· 2 days agoBUFFALO, N.Y. — The U.S. Food and Drug Administration (FDA) has expanded orphan drug designation for SurVaxM, a brain cancer immunotherapy ...
This law made ORNL a commercial powerhouse. A federal agency could jeopardize it
Knoxville News Sentinel· 3 days agoA faceoff over proposed guideline changes to the law that made Oak Ridge National Laboratory a...
AstraZeneca's Advanced Breast Cancer Drug Fails to Meet Primary Goals
Morningstar· 5 days agoAstraZeneca said a late-stage study showed that its therapy for advanced or metastatic triple-negative breast cancer didn't meet its primary goals. The British-Swedish pharma ...
AstraZeneca's (AZN) Truqap Misses Endpoints in TNBC Study
Zacks via Yahoo Finance· 5 days agoAstraZeneca's (AZN) phase III CAPItello-290 study evaluating Truqap plus chemotherapy in patients...